Table 5:
Q2 | Q3 | Q4 | |||||||
---|---|---|---|---|---|---|---|---|---|
Unadj | Adj | Without those who used SEE for education |
Unadj | Adj | Without those who used SEE for education |
Unadj | Adj | Without those who used SEE for education |
|
OR 95% CI |
OR 95% CI |
OR 95% CI |
OR 95% CI |
OR 95% CI |
OR 95% CI |
OR 95% CI |
OR 95% CI |
OR 95% CI |
|
SEE use for employment only, previous qtr | 2.891.89–4.43 | 2.741.64–4.56 | 4.182.11–8.28 | 1.09 0.66–1.82 | 0.72 0.37–1.39 | 0.95 0.44–2.09 | 1.08 0.61–1.90 | 1.06 0.55–2.06 | 1.28 0.58–2.81 |
Employment status, baseline | -- | 7.573.47–16.51 | 8.903.33–23.79 | -- | 10.683.94–28.99 | 14.834.11–53.47 | -- | 8.142.53–26.16 | 23.133.63–147.34 |
GAF symptoms, baseline | -- | 1.01 0.99–1.02 | 1.00 0.98–1.03 | -- | 0.98* 0.96–1.00 | 0.970.94–0.997 | -- | 1.01 0.99–1.02 | 1.02 0.99–1.05 |
Program site | -- | 1.00 0.95–1.05 | 1.00 0.94–1.07 | -- | 1.06 0.99–1.14 | 1.06 0.96–1.17 | -- | 1.02 0.94–1.10 | 0.98 0.89–1.08 |
Age | -- | 1.03 0.95–1.13 | 1.04 0.92–1.17 | -- | 0.96 0.87–1.07 | 0.92 0.79–1.06 | -- | 1.06 0.94–1.19 | 0.99 0.85–1.14 |
Male (ref: not male) | -- | 0.560.33–0.95 | 0.52 0.24–1.15 | -- | 0.520.27–0.99 | 0.39* 0.15–1.03 | -- | 0.52* 0.26–1.04 | 0.84 0.32–2.21 |
Race/ethnicity (ref: white non-Hispanic) | |||||||||
Black non-Hispanic | -- | 0.63 0.36–1.12 | 0.59 0.27–1.29 | -- | 0.74 0.38–1.44 | 0.48 0.19–1.23 | -- | 0.68 0.34–1.37 | 0.61 0.23–1.62 |
Hispanic | -- | 1.36 0.75–2.48 | 0.93 0.39–2.24 | -- | 1.36 0.66–2.80 | 0.78 0.28–2.16 | -- | 1.07 0.48–2.40 | 0.72 0.22–2.32 |
Other non-Hispanic | -- | 0.56 0.24–1.27 | 0.93 0.29–3.03 | -- | 0.48 0.18–1.29 | 0.29* 0.07–1.17 | -- | 0.39 0.13–1.21 | 0.140.03–0.75 |
Educational attainment at baseline (ref: less than high school) | |||||||||
High school/GED | -- | 1.61 0.80–3.21 | 0.90 0.32–2.56 | -- | 1.98 0.87–4.54 | 1.62 0.48–5.42 | -- | 1.43 0.59–3.44 | 2.06 0.59–7.18 |
Some college | -- | 2.121.16–3.88 | 1.54 0.60–3.93 | -- | 2.811.36–5.84 | 1.86 0.60–5.81 | -- | 1.79 0.83–3.86 | 2.01 0.67–5.99 |
College or more | -- | 2.05 0.73–5.73 | 1.02 0.26–3.92 | -- | 10.132.65–38.70 | 9.761.62–58.96 | -- | 2.83 0.74–10.91 | 4.94* 0.95–25.62 |
Time from onset to admission | -- | 0.960.92–0.99 | 0.930.88–0.98 | -- | 0.96 0.92–1.01 | 0.96 0.91–1.03 | -- | 0.940.90–0.99 | 0.95 0.88–1.01 |
Antipsychotic Medication adherence at baseline (ref: not adherent or adherence unknown) | |||||||||
Adherent | -- | 1.36 0.78–2.39 | 1.33 0.61–2.92 | -- | 1.991.00–3.94 | 2.49* 0.96–6.46 | -- | 0.72 0.35–1.50 | 0.63 0.24–1.63 |
No medications prescribed | -- | 2.11 0.78–5.71 | 2.17 0.52–9.04 | -- | 0.83 0.24–2.85 | 1.48 0.30–7.38 | -- | 0.79 0.22–2.78 | 0.38 0.06–2.34 |
Used substances (baseline) | -- | 1.45 0.92–2.29 | 1.931.01–3.68 | -- | 2.641.55–4.51 | 2.451.12–5.36 | -- | 1.42 0.80–2.52 | 2.03* 0.93–4.44 |
Live with parents(baseline) | -- | 0.93 0.47–1.86 | 0.90 0.37–2.20 | -- | 0.390.16–0.92 | 0.69 0.21–2.25 | -- | 0.350.14–0.91 | 0.62 0.18–2.14 |
Legal history(baseline) | -- | 2.661.16–6.11 | 0.74 0.23–2.42 | -- | 2.03 0.83–4.96 | 1.47 0.38–5.71 | -- | 2.53* 0.95–6.68 | 0.80 0.19–3.25 |
Bold indicates significance (p<0.05)
indicates approaching significance (p<0.10).